Parmax Pharma Ltd

From a low of Rs 22.60 to a fresh peak of Rs 111.27, Parmax Pharma Ltd has surged an impressive 193.36% over the past year, significantly outperforming the Sensex which declined 4.77% in the same period. This remarkable rally culminated in the stock hitting a new 52-week and all-time high on 30 Jul 2026, fuelled by a confluence of strong technical signals and sustained price momentum.

Extending its winning streak to four consecutive sessions, Parmax Pharma Ltd surged 2.00% today to touch a fresh all-time high of Rs 111.27, significantly outpacing the Sensex which declined 0.15% in the same period.

Surging to an all-time high of Rs 109.2 on 23 Jul 2026, Parmax Pharma Ltd has demonstrated remarkable momentum, rallying over 51% in the past 21 trading sessions. This micro-cap pharmaceutical stock’s ascent comes amid a broader market that remains subdued, with the Sensex trading slightly lower, underscoring the stock’s standout performance in its sector.

Extending a remarkable winning streak to 21 sessions, Parmax Pharma Ltd surged to a fresh all-time high of Rs 109.20 on 23 Jul 2026, outperforming the Sensex which declined 0.15% on the day. The stock’s 51.31% return over the past month and 222.79% year-to-date gain highlight a strong momentum that has captured market attention.

Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

From a 52-week low of Rs 22.60 to a new high of Rs 107.06, Parmax Pharma Ltd has surged an impressive 374% over the past year, significantly outpacing the Sensex’s decline of 6.54%. This remarkable rally is underpinned by a strong alignment of technical indicators and sustained price momentum, marking a notable milestone for the micro-cap pharmaceutical player.

Parmax Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 22 July 2026 by hitting its all-time high price of Rs.107.06. This achievement marks a remarkable phase in the company’s stock performance, reflecting a sustained bullish trend over recent months.

Surging past its previous ceilings, Parmax Pharma Ltd reached a new 52-week high of Rs 104.97 on 21 Jul 2026, marking a remarkable ascent from its 52-week low of Rs 22.6. This rally, driven by a confluence of strong technical signals and sustained price momentum, has propelled the stock to outperform its sector and the broader market over the past year.

Extending a remarkable winning streak to 21 sessions, Parmax Pharma Ltd surged to a fresh all-time high of Rs 104.97 on 21 Jul 2026, outperforming its sector and the broader market by a wide margin.

Surging to a new all-time high of Rs 102.92 on 20 Jul 2026, Parmax Pharma Ltd has demonstrated remarkable price momentum, rallying over 151% in the past year from its 52-week low of Rs 22.60. This milestone comes amid a 21-day consecutive gain streak, underscoring the stock’s sustained upward trajectory despite a broadly negative market backdrop.

Parmax Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 20 Jul 2026 by touching its all-time high price of Rs.102.92. This achievement marks a remarkable phase in the company’s stock performance, reflecting sustained gains over the past several weeks and a notable outperformance relative to key market benchmarks.

Surging past its previous peaks, Parmax Pharma Ltd touched a fresh 52-week high of Rs 100.91 on 17 Jul 2026, marking a remarkable 151.9% gain over the past year. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum that has captivated market attention.

Parmax Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching its all-time high price of Rs.100.91 on 17 July 2026, marking a remarkable phase in its market journey.

Surging past the Rs 98.94 mark on 16 Jul 2026, Parmax Pharma Ltd has achieved a significant milestone by hitting a new 52-week high. This breakout caps a remarkable 51.31% gain over the past 21 trading sessions, underscoring the stock’s robust momentum amid a broadly positive market backdrop.

Parmax Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 16 July 2026 by touching its all-time high price of Rs.98.94. This achievement marks a remarkable phase in the company’s stock performance, reflecting a sustained bullish trend and notable gains over multiple time frames.

Surging to a fresh 52-week and all-time high of Rs 97.06 on 15 Jul 2026, Parmax Pharma Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 55.84% gain over the past 21 trading days.